welbournes

MHRA Class 3 Medicines Recall: Urospir 50mg/5ml Oral Solution Drug Alert Number: EL(25)A/14 Date issued: 02 April 2025 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall notice for: Urospir 50mg/5ml Oral Solution DMRC reference number: DMRC-35150350 Marketing Authorisation Holder:Rosemont Pharmaceuticals Ltd Product name: Urospir 50mg/5ml Oral Solution SNOMED code: [...]

The post MHRA Class 3 Medicines Recall: Urospir 50mg/5ml Oral Solution appeared first on Community Pharmacy England.

Drug alert number: EL (25)A/13 Date issued: 01 April 2025 Uni Health Distribution Ltd has informed the MHRA of a typographical error on the approved carton overlabel for certain batches of Utrogestan Vaginal 200 mg Capsules. The carton label references ‘micrograms’ where it should actually state ‘milligrams’. Utrogestan Vaginal 200 mg Capsules, PLPI 45396/0316 Batch [...]

The post MHRA Class 2 Medicines Recall: Utrogestan Vaginal 200 mg Capsules (progesterone) appeared first on Community Pharmacy England.

The following price concessions granted in March 2025 have rolled over to April 2025: Drug Pack size March 2025 price concession Fusidic acid 1% modified-release eye drops 5 £21.00 Oxybutynin 2.5mg tablets 56 £1.11 Timolol 0.5% eye drops 5 £1.63 Venlafaxine 300mg modified-release tablets 30 £43.09 Please note any rolled over prices can be adjusted [...]

The post Rolled over price concessions for April 2025 appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (31/03/2025) announced the following final list of price concessions for March 2025: Drug Pack size Price concession Ascorbic acid 500mg tablets 28 £36.08 Captopril 50mg tablets 56 £23.50 [...]

The post March 2025 Price Concessions Final Update appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Apraclonidine (Iopidine®) 5mg/ml (0.5%) eye drops.  MSN/2025/018 Tier 2 – medium impact Date of issue: 27th March 2025 Apraclonidine (Iopidine®) 5mg/ml (0.5%) eye drops are out of stock until early September 2025. Limited supplies of parallel imported apraclonidine (Iopidine®) 5mg/ml (0.5%) [...]

The post Medicine Supply Notification: Apraclonidine (Iopidine® ) 5mg/ml (0.5%) eye drops appeared first on Community Pharmacy England.